• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4603663)   Today's Articles (4904)   Subscriber (49370)
For: Senechal M, Demers S, Cantin B, Bourgault C, Leblanc MH, Morin J, Couture C. Usefulness and Limitations of Rituximab in Managing Patients With Lymphoproliferative Disorder After Heart Transplantation. EXP CLIN TRANSPLANT 2012;10:513-8. [DOI: 10.6002/ect.2012.0012] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Number Cited by Other Article(s)
1
Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity. Sci Rep 2015;5:15712. [PMID: 26508306 PMCID: PMC4623742 DOI: 10.1038/srep15712] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Accepted: 09/10/2015] [Indexed: 01/10/2023]  Open
2
Meyer SC, Medinger M, Halter JP, Baldomero H, Hirsch HH, Tzankov A, Dirnhofer S, Passweg JR, Tichelli A. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. ACTA ACUST UNITED AC 2013;19:280-5. [PMID: 24074746 DOI: 10.1179/1607845413y.0000000123] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA